Siemens Mammomat Revelation

On November 26, 2017 the Siemens Healthineers company provided the innovation system for Mammomat Revelation mammography. By the time of the announcement this device still expects registration in FDA and also undergoes testing in three research centers of Europe.

Siemens represents a system for Mammomat Revelation mammography

Mammomat Revelation is equipped with HD Breast Tomosynthesis technology for more exact taking of a biopsy of a mammary gland (to within ± in 1 mm).

Traditionally bioptata are estimated in other premises or using the separate device because of what the procedure of taking of a biopsy drags on. The instrument of visualization InSpect which allows the doctor to estimate success of a biopsy directly when carrying out mammography is integrated into Memmomat Revelation.

Besides, Mammomat Revelation automatically measures density of tissues of breast during inspection. It allows to personalize stratification of risk so the patient should not return to additional inspection – necessary pictures will be made at the first address.

A system has function of the personalized soft compression thanks to which force of compression is automatically configured under each patient. Having recorded a certain degree of resistance, a system reduces compression force that reduces painful feelings during mammography, so, increases commitment of patients to carrying out this screening research.

"It is known that many women avoid repeated mammography because of pain and discomfort during the procedure, – Lars Hofmann, the head of marketing in the field of roentgenography of Siemens Healthiners company explained. – Therefore we made so many efforts to achieve compression personalisation".

Besides, Mammomat Revelation allows doctors to conduct researches with uses of contrast that plays an important role in identification of the masked defeats. Hoffmann considers that such device can become economic replacement of MRT of a mammary gland which is available not in all^[1].

Notes